192 related articles for article (PubMed ID: 11877672)
1. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets during endotoxic shock.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2002 Mar; 37(3):482-7. PubMed ID: 11877672
[TBL] [Abstract][Full Text] [Related]
2. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
Chin A; Radhakrishnan J; Fornell L; John E
J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
[TBL] [Abstract][Full Text] [Related]
3. Differentiated and dose-related cardiovascular effects of a dual endothelin receptor antagonist in endotoxin shock.
Konrad D; Oldner A; Rossi P; Wanecek M; Rudehill A; Weitzberg E
Crit Care Med; 2004 May; 32(5):1192-9. PubMed ID: 15190972
[TBL] [Abstract][Full Text] [Related]
4. The endothelin receptor antagonist tezosentan improves renal microcirculation in a porcine model of endotoxemic shock.
Fenhammar J; Andersson A; Frithiof R; Forestier J; Weitzberg E; Sollevi A; Hjelmqvist H
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1385-93. PubMed ID: 19025532
[TBL] [Abstract][Full Text] [Related]
5. Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
Somell A; Weitzberg E; Suneson A; Sollevi A; Hjelmqvist H
Acta Physiol (Oxf); 2007 Aug; 190(4):291-302. PubMed ID: 17498196
[TBL] [Abstract][Full Text] [Related]
6. Endothelin mediates the altered renal hemodynamics associated with experimental congestive heart failure.
Qiu C; Ding SS; Hess P; Clozel JP; Clozel M
J Cardiovasc Pharmacol; 2001 Aug; 38(2):317-24. PubMed ID: 11483881
[TBL] [Abstract][Full Text] [Related]
7. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
[TBL] [Abstract][Full Text] [Related]
8. Tezosentan attenuates organ injury and mesenteric blood flow decrease in endotoxemia and cecal ligation and puncture.
Erdem A; Meltem Sevgili A; Akbiyik F; Atilla P; Cakar N; Balkanci ZD; Iskit AB; Guc MO
J Surg Res; 2007 Aug; 141(2):211-9. PubMed ID: 17583743
[TBL] [Abstract][Full Text] [Related]
9. The effect of tezosentan after cold ischemia and renal artery clamping as a model of reperfusion injury in newborn piglets.
Pham J; Beier UH; Fornell L; Chin A; Samuel S; Radhakrishnan J; John E
Transplant Proc; 2008 Jun; 40(5):1294-9. PubMed ID: 18589090
[TBL] [Abstract][Full Text] [Related]
10. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
11. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome.
Wong F; Moore K; Dingemanse J; Jalan R
Hepatology; 2008 Jan; 47(1):160-8. PubMed ID: 17886336
[TBL] [Abstract][Full Text] [Related]
12. Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs.
Wang L; Zhu DM; Su X; Bai CX; Ware LB; Matthay MA
Exp Lung Res; 2004; 30(1):31-42. PubMed ID: 14967602
[TBL] [Abstract][Full Text] [Related]
13. Dual endothelin receptor blockade with tezosentan markedly attenuates hypoxia-induced pulmonary vasoconstriction in a porcine model.
Hedelin P; Kylhammar D; Rådegran G
Acta Physiol (Oxf); 2012 Mar; 204(3):419-34. PubMed ID: 21726419
[TBL] [Abstract][Full Text] [Related]
14. Short-term endothelin receptor blockade with tezosentan has both immediate and long-term beneficial effects in rats with myocardial infarction.
Clozel M; Qiu C; Qiu CS; Hess P; Clozel JP
J Am Coll Cardiol; 2002 Jan; 39(1):142-7. PubMed ID: 11755300
[TBL] [Abstract][Full Text] [Related]
15. Mixed endothelin receptor antagonism with tezosentan improves intestinal microcirculation in endotoxemic shock.
Andersson A; Fenhammar J; Frithiof R; Weitzberg E; Sollevi A; Hjelmqvist H
J Surg Res; 2008 Sep; 149(1):138-47. PubMed ID: 18639249
[TBL] [Abstract][Full Text] [Related]
16. The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function.
Wilhelm SM; Stowe NT; Robinson AV; Schulak JA
Transplantation; 2001 Jan; 71(2):211-6. PubMed ID: 11213061
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.
Torre-Amione G; Young JB; Colucci WS; Lewis BS; Pratt C; Cotter G; Stangl K; Elkayam U; Teerlink JR; Frey A; Rainisio M; Kobrin I
J Am Coll Cardiol; 2003 Jul; 42(1):140-7. PubMed ID: 12849674
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 blockade corrects mesenteric hypoperfusion in a porcine low cardiac output model.
Burgener D; Laesser M; Treggiari-Venzi M; Oi Y; Jolliet P; Strasser S; Hadengue A; Aneman A
Crit Care Med; 2001 Aug; 29(8):1615-20. PubMed ID: 11505140
[TBL] [Abstract][Full Text] [Related]
19. Cardiac effects of endothelin receptor antagonism in endotoxemic pigs.
Konrad D; Haney M; Johansson G; Wanecek M; Weitzberg E; Oldner A
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H988-96. PubMed ID: 17400719
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.
Torre-Amione G; Young JB; Durand J; Bozkurt B; Mann DL; Kobrin I; Pratt CM
Circulation; 2001 Feb; 103(7):973-80. PubMed ID: 11181472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
